Suppr超能文献

植入式端口通畅性:肝素与生理盐水的比较。

Implanted Port Patency: Comparing Heparin and Normal Saline.

机构信息

HonorHealth Medical Center.

出版信息

Clin J Oncol Nurs. 2021 Apr 1;25(2):169-173. doi: 10.1188/21.CJON.169-173.

Abstract

BACKGROUND

To maintain implanted port patency, clinicians can better determine the difference between the use of heparin and normal saline, including risk to patients, unnecessary cost to the healthcare system, and whether heparin is effective in maintaining port patency.

OBJECTIVES

The aim is to compare the effectiveness of saline to heparin for maintaining implanted port patency and to evaluate the cost differences.

METHODS

Data were collected from 56 patients enrolled in oncology clinical trials; 37 had paired data.

FINDINGS

Results showed that saline was as effective as heparin in maintaining implanted port patency. The difference in mean cost of saline versus heparin was statistically significant. Eliminating heparin when locking implanted ports did not increase catheter occlusion rates.

摘要

背景

为了保持植入式港的通畅,临床医生可以更好地判断肝素和生理盐水的使用效果的差异,包括对患者的风险、对医疗系统的不必要成本,以及肝素是否有效地保持港的通畅。

目的

比较生理盐水和肝素在维持植入式港通畅方面的效果,并评估成本差异。

方法

从参加肿瘤临床试验的 56 名患者中收集数据;其中 37 名患者有配对数据。

发现

结果表明,生理盐水与肝素在维持植入式港通畅方面同样有效。生理盐水与肝素的平均成本差异具有统计学意义。在锁定植入港时不使用肝素不会增加导管堵塞率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验